Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology

JP Droz, L Balducci, M Bolla, M Emberton… - BJU …, 2010 - Wiley Online Library
Prostate cancer is the most prevalent cancer in men and predominantly affects older men
(aged≥ 70 years). The median age at diagnosis is 68 years; overall, two‐thirds of prostate …

Upgrading and downgrading of prostate cancer from biopsy to radical prostatectomy: incidence and predictive factors using the modified Gleason grading system and …

JI Epstein, Z Feng, BJ Trock, PM Pierorazio - European urology, 2012 - Elsevier
BACKGROUND: Prior studies assessing the correlation of Gleason score (GS) at needle
biopsy and corresponding radical prostatectomy (RP) predated the use of the modified …

Impact of age at diagnosis on prostate cancer treatment and survival

SK Bechis, PR Carroll, MR Cooperberg - Journal of Clinical Oncology, 2011 - ascopubs.org
Purpose Older men are more likely to be diagnosed with high-risk prostate cancer and to
have lower overall survival. As a result, age often plays a role in treatment choice. However …

Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence

SA Boorjian, RH Thompson, MK Tollefson, LJ Rangel… - European urology, 2011 - Elsevier
BACKGROUND: The natural history of biochemical recurrence (BCR) after radical retropubic
prostatectomy (RRP) is variable and does not always translate into systemic progression or …

[HTML][HTML] Age at diagnosis and prostate cancer treatment and prognosis: a population-based cohort study

A Pettersson, D Robinson, H Garmo, L Holmberg… - Annals of …, 2018 - Elsevier
Background Old age at prostate cancer diagnosis has been associated with poor prognosis
in several studies. We aimed to investigate the association between age at diagnosis and …

Age 70+/-5 years and cancer-specific outcomes after treatment of localized prostate cancer: a systematic review

H Shaheen, MA Salans, O Mohamad… - International Journal of …, 2024 - Elsevier
A secondary analysis of 2 randomized Radiation Therapy Oncology Group trials
demonstrated that age≥ 70 years was a favorable prognostic factor among men treated with …

Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer

A Briganti, S Joniau, P Gontero, F Abdollah… - European urology, 2012 - Elsevier
BACKGROUND: The current role of radical prostatectomy (RP) in patients with high-risk
disease remains controversial. OBJECTIVE: To identify which high-risk prostate cancer …

Men older than 70 years have higher risk prostate cancer and poorer survival in the early and late prostate specific antigen eras

L Sun, AA Caire, CN Robertson, DJ George… - The Journal of …, 2009 - Elsevier
PURPOSE: We clarified whether men older than 70 years have a higher risk of prostate
cancer and poorer survival in the early and late prostate specific antigen eras. MATERIALS …

Association between oncotype DX genomic prostate score and adverse tumor pathology after radical prostatectomy

MC Moschovas, C Chew, S Bhat, M Sandri… - European urology …, 2022 - Elsevier
Abstract Background The Oncotype DX assay is a clinically validated 17-gene genomic
assay that provides a genomic prostate score (GPS; scale 0–100) measuring the …

Robot‐assisted radical prostatectomy in men aged≥ 70 years

KA Greco, JJ Meeks, S Wu, RB Nadler - BJU international, 2009 - Wiley Online Library
OBJECTIVES To assess the outcomes of elderly men with prostate cancer treated with robot‐
assisted radical prostatectomy (RARP), because more healthy elderly men will present with …